Budget cap and pay-back model to control spending on medicines: A case study of Bulgaria

Central and Eastern European countries (CEEC) have among the highest rates of increase in healthcare expenditure. External reference pricing, generics and biologics price capping, regressive scale for price setting, health technology assessment (HTA), and positive drug lists for reimbursed medicines...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitkova, Zornitsa, Dimitrova, Maria, Doneva, Miglena, Tachkov, Konstantin, Kamusheva, Maria, Marinov, Lyubomir, Gerasimov, Nikolay, Tcharaktchiev, Dimitar, Petrova, Guenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691655/
https://www.ncbi.nlm.nih.gov/pubmed/36438231
http://dx.doi.org/10.3389/fpubh.2022.1011928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691655/
https://www.ncbi.nlm.nih.gov/pubmed/36438231
http://dx.doi.org/10.3389/fpubh.2022.1011928

Ejemplares similares